Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
2.560
+0.040 (1.59%)
At close: Aug 1, 2025, 4:00 PM
2.650
+0.090 (3.52%)
After-hours: Aug 1, 2025, 4:41 PM EDT
IMDX Employees
As of December 31, 2024, Insight Molecular Diagnostics had 49 total employees, including 46 full-time and 3 part-time employees. The number of employees increased by 3 or 6.52% compared to the previous year.
Employees
49
Change (1Y)
3
Growth (1Y)
6.52%
Revenue / Employee
$78,429
Profits / Employee
-$1,189,020
Market Cap
74.36M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49 | 3 | 6.52% |
Dec 31, 2023 | 46 | -30 | -39.47% |
Dec 31, 2022 | 76 | -39 | -33.91% |
Dec 31, 2021 | 115 | 64 | 125.49% |
Dec 31, 2020 | 51 | 18 | 54.55% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IMDX News
- 2 days ago - IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients - GlobeNewsWire
- 4 days ago - iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025 - GlobeNewsWire
- 5 weeks ago - iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing - GlobeNewsWire
- 6 weeks ago - Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville - GlobeNewsWire
- 2 months ago - Medicare Boosts Reimbursement for Oncocyte's Flagship Technology - GlobeNewsWire
- 2 months ago - OncoCyte Corporation (OCX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Oncocyte Reports Q1 2025 Results and Business Progress - GlobeNewsWire
- 3 months ago - Oncocyte to Release First Quarter 2025 Results on May 12, 2025 - GlobeNewsWire